Viking Therapeutics Stock Forward View
| VKTX Stock | USD 26.29 3.27 11.06% |
Viking Stock outlook is based on your current time horizon.
At this time the rsi of Viking Therapeutics' share price is below 20 . This entails that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.73) | EPS Estimate Current Year (2.61) | EPS Estimate Next Year (3.72) | Wall Street Target Price 93.3889 | EPS Estimate Current Quarter (0.67) |
Using Viking Therapeutics hype-based prediction, you can estimate the value of Viking Therapeutics from the perspective of Viking Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Viking Therapeutics using Viking Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Viking using crowd psychology based on the activity and movement of Viking Therapeutics' stock price.
Viking Therapeutics Short Interest
An investor who is long Viking Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Viking Therapeutics and may potentially protect profits, hedge Viking Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 31.1855 | Short Percent 0.2664 | Short Ratio 8.18 | Shares Short Prior Month 24.3 M | 50 Day MA 34.244 |
Viking Relative Strength Index
The Naive Prediction forecasted value of Viking Therapeutics on the next trading day is expected to be 25.28 with a mean absolute deviation of 1.26 and the sum of the absolute errors of 78.30.Viking Therapeutics Hype to Price Pattern
Investor biases related to Viking Therapeutics' public news can be used to forecast risks associated with an investment in Viking. The trend in average sentiment can be used to explain how an investor holding Viking can time the market purely based on public headlines and social activities around Viking Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Viking Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Viking Therapeutics.
Viking Therapeutics Implied Volatility | 0.86 |
Viking Therapeutics' implied volatility exposes the market's sentiment of Viking Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Viking Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Viking Therapeutics stock will not fluctuate a lot when Viking Therapeutics' options are near their expiration.
The Naive Prediction forecasted value of Viking Therapeutics on the next trading day is expected to be 25.28 with a mean absolute deviation of 1.26 and the sum of the absolute errors of 78.30.
Viking Therapeutics after-hype prediction price | USD 25.57 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Viking Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Viking contract
Based on the Rule 16, the options market is currently suggesting that Viking Therapeutics will have an average daily up or down price movement of about 0.0538% per day over the life of the 2026-05-15 option contract. With Viking Therapeutics trading at USD 26.29, that is roughly USD 0.0141 . If you think that the market is fully incorporating Viking Therapeutics' daily price movement you should consider acquiring Viking Therapeutics options at the current volatility level of 0.86%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-05-15 Viking Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Viking Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Viking Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Viking Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Viking Therapeutics' open interest, investors have to compare it to Viking Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Viking Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Viking. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Viking Therapeutics Additional Predictive Modules
Most predictive techniques to examine Viking price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Viking using various technical indicators. When you analyze Viking charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Viking Therapeutics' financial statements to predict how it will affect future prices.
Cash | First Reported 2013-09-30 | Previous Quarter 33.9 M | Current Value 100.4 M | Quarterly Volatility 38.7 M |
Viking Therapeutics Naive Prediction Price Forecast For the 7th of February
Given 90 days horizon, the Naive Prediction forecasted value of Viking Therapeutics on the next trading day is expected to be 25.28 with a mean absolute deviation of 1.26, mean absolute percentage error of 2.16, and the sum of the absolute errors of 78.30.Please note that although there have been many attempts to predict Viking Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Viking Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Viking Therapeutics Stock Forecast Pattern
| Backtest Viking Therapeutics | Viking Therapeutics Price Prediction | Research Analysis |
Viking Therapeutics Forecasted Value
In the context of forecasting Viking Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Viking Therapeutics' downside and upside margins for the forecasting period are 21.42 and 29.14, respectively. We have considered Viking Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Viking Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Viking Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 120.7172 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.2629 |
| MAPE | Mean absolute percentage error | 0.0363 |
| SAE | Sum of the absolute errors | 78.2979 |
Predictive Modules for Viking Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Viking Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Viking Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Viking Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Viking Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Viking Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Viking Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Viking Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Viking Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Viking Therapeutics' historical news coverage. Viking Therapeutics' after-hype downside and upside margins for the prediction period are 21.81 and 29.33, respectively. We have considered Viking Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Viking Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Viking Therapeutics is based on 3 months time horizon.
Viking Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Viking Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Viking Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Viking Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.53 | 3.86 | 0.84 | 0.78 | 10 Events / Month | 7 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
26.29 | 25.57 | 2.74 |
|
Viking Therapeutics Hype Timeline
Viking Therapeutics is at this time traded for 26.29. The entity has historical hype elasticity of -0.84, and average elasticity to hype of competition of 0.78. Viking is anticipated to decline in value after the next headline, with the price expected to drop to 25.57. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -2.74%, whereas the daily expected return is at this time at -0.53%. The volatility of related hype on Viking Therapeutics is about 262.23%, with the expected price after the next announcement by competition of 27.07. About 65.0% of the company outstanding shares are owned by institutional investors. The book value of Viking Therapeutics was at this time reported as 6.34. The company recorded a loss per share of 2.13. Viking Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out Historical Fundamental Analysis of Viking Therapeutics to cross-verify your projections.Viking Therapeutics Related Hype Analysis
Having access to credible news sources related to Viking Therapeutics' direct competition is more important than ever and may enhance your ability to predict Viking Therapeutics' future price movements. Getting to know how Viking Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Viking Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CRNX | Crinetics Pharmaceuticals | 1.30 | 9 per month | 2.57 | 0.02 | 3.94 | (5.06) | 21.15 | |
| KYMR | Kymera Therapeutics | (0.35) | 10 per month | 2.61 | 0.07 | 4.40 | (4.46) | 49.42 | |
| IMVT | Immunovant | (0.64) | 12 per month | 0.00 | (0.02) | 4.03 | (3.65) | 11.43 | |
| NAMS | NewAmsterdam Pharma | (1.41) | 11 per month | 0.00 | (0.09) | 4.50 | (4.89) | 13.34 | |
| PRAX | Praxis Precision Medicines | 15.51 | 9 per month | 3.82 | 0.13 | 9.33 | (6.06) | 36.21 | |
| AKRO | Akero Therapeutics | (0.25) | 4 per month | 0.63 | 0.11 | 3.29 | (2.12) | 16.73 | |
| SLNO | Soleno Therapeutics | 0.25 | 11 per month | 0.00 | (0.15) | 5.40 | (5.49) | 26.59 | |
| AAPG | Ascentage Pharma Group | 0.48 | 8 per month | 0.00 | (0.14) | 5.25 | (6.36) | 16.72 | |
| ACAD | ACADIA Pharmaceuticals | 0.84 | 9 per month | 1.90 | 0.01 | 3.35 | (2.94) | 12.09 | |
| LGND | Ligand Pharmaceuticals Incorporated | (1.01) | 12 per month | 2.12 | (0.01) | 3.51 | (3.06) | 18.09 |
Other Forecasting Options for Viking Therapeutics
For every potential investor in Viking, whether a beginner or expert, Viking Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Viking Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Viking. Basic forecasting techniques help filter out the noise by identifying Viking Therapeutics' price trends.Viking Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Viking Therapeutics stock to make a market-neutral strategy. Peer analysis of Viking Therapeutics could also be used in its relative valuation, which is a method of valuing Viking Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Viking Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Viking Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Viking Therapeutics shares will generate the highest return on investment. By undertsting and applying Viking Therapeutics stock market strength indicators, traders can identify Viking Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 577860.0 | |||
| Daily Balance Of Power | (1.14) | |||
| Rate Of Daily Change | 0.89 | |||
| Day Median Price | 27.21 | |||
| Day Typical Price | 26.9 | |||
| Price Action Indicator | (2.55) | |||
| Period Momentum Indicator | (3.27) |
Viking Therapeutics Risk Indicators
The analysis of Viking Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Viking Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting viking stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.74 | |||
| Standard Deviation | 3.86 | |||
| Variance | 14.86 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Viking Therapeutics
The number of cover stories for Viking Therapeutics depends on current market conditions and Viking Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Viking Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Viking Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Viking Therapeutics Short Properties
Viking Therapeutics' future price predictability will typically decrease when Viking Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Viking Therapeutics often depends not only on the future outlook of the potential Viking Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Viking Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 109 M | |
| Cash And Short Term Investments | 902.6 M |
Additional Tools for Viking Stock Analysis
When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.